Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-006899
Filing Date
2025-09-09
Accepted
2025-09-09 16:27:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3312
  Complete submission text file 0001950047-25-006899.txt   4843
Mailing Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036
Business Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036 929-999-4055
Dianthus Therapeutics, Inc. /DE/ (Subject) CIK: 0001690585 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38541 | Film No.: 251303593
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036
Business Address
Savitz Ryan (Reporting) CIK: 0001992324 (see all company filings)

Type: 144